International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 4 , Pages 1073-1080 , 15 November 2010

Stereotactic Body Radiotherapy for Patients With Unresectable Primary Hepatocellular Carcinoma: Dose-Volumetric Parameters Predicting the Hepatic Complication

  • Seok Hyun Son, M.D.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, the Catholic University of Korea, Seoul, Korea
    • ,
  • Byung Ock Choi, M.D.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, the Catholic University of Korea, Seoul, Korea
    • ,
  • Mi Ryeong Ryu, M.D.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, the Catholic University of Korea, Seoul, Korea
    • ,
  • Young Nam Kang, Ph.D.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, the Catholic University of Korea, Seoul, Korea
    • ,
  • Ji Sun Jang, M.S.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, the Catholic University of Korea, Seoul, Korea
    • ,
  • Si Hyun Bae, M.D.

      Affiliations

    • Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul, Korea
    • ,
  • Seung Kew Yoon, M.D.

      Affiliations

    • Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul, Korea
    • ,
  • Ihl Bohng Choi, M.D.

      Affiliations

    • Cyberknife Center of Gimpo Wooridul Spine Hospital, Seoul, Korea
    • ,
  • Ki Mun Kang, M.D.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, Gyeongsang National University, Jinju, Korea
    • ,
  • Hong Seok Jang, M.D.

      Affiliations

    • Department of Radiation Oncology, College of Medicine, the Catholic University of Korea, Seoul, Korea
    • Corresponding Author InformationReprint requests to: Hong Seok Jang, M.D., Depart. of Radiation Oncology, Seoul St. Mary's Hospital, 505, Banpo-dong, Seocho-gu, Seoul, Korea. Tel: 82-2-2258-6257; Fax: 82-2-2258-1532

Received 2 July 2009 ,Revised 4 September 2009 ,Accepted 4 September 2009.

References 

  1. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918–928
  2. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156
  3. Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterol. 2004;127:1714–1723
  4. Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials. Radiology. 2002;224:47–54
  5. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology. 2001;221:159–166
  6. Orlando A, Cottone M, Virdone R, et al. Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection. A trial with a comparison group. Scand J Gastroenterol. 1997;32:598–603
  7. Lencioni R, Pinto F, Armillotta N, et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience. Eur Radiol. 1997;7:514–519
  8. Cochrane AM, Murray-Lyon IM, Brinkley DM, et al. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma. Cancer. 1977;40:609–614
  9. Lewin K, Millis RR. Human radiation hepatitis. A morphologic study with emphasis on the late changes. Arch Pathol. 1973;96:21–26
  10. Lawrence TS, Robertson JM, Anscher MS, et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31:1237–1248
  11. Shim SJ, Seong J, Han KH, et al. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma. Liver Int. 2005;25:1189–1196
  12. Park W, Lim DH, Paik SW, et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:1143–1150
  13. Cheng JC, Chuang VP, Cheng SH, et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2000;47:435–442
  14. Seong J, Keum KC, Han KH, et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:393–397
  15. Robertson JM, McGinn CJ, Walker S, et al. A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. Int J Radiat Oncol Biol Phys. 1997;39:1087–1092
  16. Tse RV, Hawkins M, Lockwood G, et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2008;26:657–664
  17. Takeda A, Takahashi M, Kunieda E, et al. Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity. Hepatol Res. 2008;38:60–69
  18. Choi BO, Choi IB, Jang HS, et al. Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: Preliminary analysis. BMC Cancer. 2008;8:351–357
  19. Choi BO, Jang HS, Kang KM, et al. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol. 2006;36:154–158
  20. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol. 2001;19:164–170
  21. Cheng JC, Wu JK, Huang CM, et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication. Int J Radiat Oncol Biol Phys. 2002;54:156–162
  22. Lee IJ, Seong J, Shim SJ, et al. Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:154–158
  23. Kim TH, Kim DY, Park JW, et al. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:225–231
  24. Dawson LA, Normolle D, Balter JM, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53:810–821
  25. Zhu J, Zhu XD, Liang SX, et al. Prediction of radiation induced liver disease using artificial neural networks. Jpn J Clin Oncol. 2006;36:783–788
  26. Liang SX, Zhu XD, Xu ZY, et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys. 2006;65:426–434
  27. Ogata K, Hizawa K, Yoshida M, et al. Hepatic injury following irradiation—A morphologic study. Tokushima J Exp Med. 1963;43:240–251
  28. Kim JH, Park JW, Kim TH, et al. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2007;69:813–819
  29. Furuse J, Ishii H, Nagase M, et al. Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol. 2005;20:1512–1518
  30. Meyer JL, Hinkelbein W. Frontiers of radiation therapy and oncology. Vol. 40. Basel: Karger; 2007;p. 418

 Conflicts of interest: none.

PII: S0360-3016(09)03202-7

doi: 10.1016/j.ijrobp.2009.09.009

International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 4 , Pages 1073-1080 , 15 November 2010

Article Tools

* Image Usage & Resolution